Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells (original) (raw)

Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations

Bente Frølund

Journal of medicinal chemistry, 2005

View PDFchevron_right

Allosteric modifiers of neuronal nicotinic acetylcholine receptors: New methods, new opportunities

Krzysztof Jozwiak, Irving Wainer

Medicinal Research Reviews, 2007

View PDFchevron_right

MK-8825: A potent and selective CGRP receptor antagonist with good oral activity in rats

Scott Mosser

Bioorganic & Medicinal Chemistry Letters, 2012

View PDFchevron_right

Brain Neuronal Nicotinic Receptors as New Targets for Drug Discovery

Francesco Clementi

Current Pharmaceutical Design, 2006

View PDFchevron_right

Calcitonin Gene-Related Peptide Rapidly Downregulates Nicotinic Receptor Function and Slowly Raises Intracellular Ca2+in Rat Chromaffin CellsIn Vitro

A. Nistri

The Journal of Neuroscience, 1999

View PDFchevron_right

The discovery of highly potent CGRP receptor antagonists

Craig Stump, Ian Bell

Bioorganic & Medicinal Chemistry Letters, 2009

View PDFchevron_right

A Novel Class of Peptides with Facilitating Action on Neuronal Nicotinic Receptors of Rat Chromaffin Cells in Vitro: Functional and Molecular Dynamics Studies

Silvia Di Angelantonio

Molecular Pharmacology, 2002

View PDFchevron_right

A-85380: A Pharmacological Probe for the Preclinical and Clinical Investigation of the ? 4 ? 2 Neuronal Nicotinic Acetylcholine Receptor

Diana Donnelly-Roberts

CNS Drug Reviews, 2006

View PDFchevron_right

A Novel Pharmatope Tag Inserted into the 4 Subunit Confers Allosteric Modulation to Neuronal Nicotinic Receptors

E. Hawrot

Journal of Biological Chemistry, 2004

View PDFchevron_right

The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents

Edwin Johnson

Life Sciences, 1998

View PDFchevron_right

A Novel Pharmatope Tag Inserted into the β4 Subunit Confers Allosteric Modulation to Neuronal Nicotinic Receptors

Tanya Sanders

Journal of Biological Chemistry, 2004

View PDFchevron_right

Competition, Selectivity and Efficacy of Analogs of A-84543 for Nicotinic Acetylcholine Receptors with Repositioning of Pyridine Nitrogen

Martha I. Dávila-García

Neurochemical Research, 2015

View PDFchevron_right

Autonomic function in mice lacking 5 neuronal nicotinic acetylcholine receptor subunit

Ruth Rabinowitz

The Journal of Physiology, 2002

View PDFchevron_right

Unconventional ligands and modulators of nicotinic receptors

Alfred Maelicke

Journal of Neurobiology, 2002

View PDFchevron_right

Effect of novel negative allosteric modulators of neuronal nicotinic receptors on cells expressing native and recombinant nicotinic receptors: implications for drug discovery

Thomas Boyd

2009

View PDFchevron_right

Calcitonin gene-related peptide (CGRP) receptor antagonists: Novel aspartates and succinates

Valerie Whiterock

Bioorganic & Medicinal Chemistry Letters, 2012

View PDFchevron_right

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

Henri Doods

British Journal of Pharmacology, 2000

View PDFchevron_right

International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits

Michael Marks

Pharmacological reviews, 1999

View PDFchevron_right

Structural and functional diversity of native brain neuronal nicotinic receptors

Francesco Clementi

Biochemical Pharmacology, 2009

View PDFchevron_right

A novel m-conopeptide , CnIIIC , exerts potent and preferential inhibition of NaV 1 . 2 / 1 . 4 channels and blocks neuronal nicotinic acetylcholine receptors

Enrico Leipold

2012

View PDFchevron_right

Structural differences determine the relative selectivity of nicotinic compounds for native α4β2*-, α6β2*-, α3β4*- and α7-nicotine acetylcholine receptors

Henry Lester

Neuropharmacology, 2010

View PDFchevron_right

The Interaction of Quaternary Reversible Acetylcholinesterase Inhibitors With the Nicotinic Receptor

Filip Zemek

Physiological Research, 2014

View PDFchevron_right

A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors

hubert gaertner

British Journal of Pharmacology, 2012

View PDFchevron_right